CL
LKFT

CSS LLC’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

CSS LLC’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-599
Closed -$26K – 1008
2022
Q3 		$26K Buy
+599
New +$30.7K ﹤0.01% 919
2022
Q1 		– Sell
-7,458
Closed -$456K – 1214
2021
Q4 		$411K Buy
7,458
+1,694
+29% +$88.4K 0.01% 717
2021
Q3 		$303K Buy
+5,764
New +$342K 0.01% 776

Other funds holding LKFT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

CSS LLC's LKFT Position: Q4 2022 in Review

CSS LLC sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2022, closing a stake of 599 shares — an estimated $26K sold.

CSS LLC first reported a position in LKFT in Q3 2021 and held it in 3 quarters. The position peaked at $411K in Q4 2021. 75 funds tracked by Wall St. Rank hold LKFT as of Q4 2022.

  • CSS LLC reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • CSS LLC sold 599 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2022, an estimated $26K.
  • CSS LLC first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2021 and held it in 3 quarters.
  • CSS LLC's Lakefront Biotherapeutics American Depositary Shares position peaked at $411K in Q4 2021.
  • 75 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2022.

Based on CSS LLC's 13F filing for Q4 2022, filed 14 Feb 2023.